Literature DB >> 16714773

Changes in the expression and/or activation of regulatory proteins in rat hearts adapted to chronic hypoxia.

M Strnisková1, T Ravingerová, J Neckár, F Kolár, S Pastoreková, M Barancík.   

Abstract

Chronic intermittent high altitude (IHA) hypoxia results in long-term adaptation protecting the heart against acute ischemia/reperfusion injury; however, molecular mechanisms of this phenomenon are not completely elucidated so far. The present study was aimed at investigation of a modulating effect of IHA hypoxia on the expression and/or activation of selected regulatory proteins, with particular emphasis on differential responses in the right ventricle (RV) and left ventricle (LV). Adult male Wistar rats were exposed to IHA hypoxia of 7000 m simulated in a hypobaric chamber (8 h/day, 25 exposures), and protein contents and activities in myocardial fractions were determined by Western blot analysis. In markedly hypertrophic RV of hypoxic rats, gelatinolytic activity of MMP-2 and protein levels of carbonic anhydrase IX (a marker of hypoxia) were significantly enhanced. Study of mitogen-activated protein kinases (MAPKs) revealed no differences in the contents of total p38-MAPK in both ventricles between the IHA and normoxic control rats, whereas activation of p38-MAPK was decreased in the RV and moderately increased in the LV of IHA rats as compared to controls. Extracellular signal regulated kinase-2 (ERK-2) was partially up-regulated in the RV of IHA rats, and, in addition, expression of acidic fibroblast growth factor (aFGF), a potential activator of ERK cascade, was also significantly increased. In contrast, expression of ERKs in the LV as well as their activities in both ventricles, were not affected by IHA hypoxia. Differential effects of IHA hypoxia on c-Jun-N-terminal protein kinases (JNKs) in the RV and LV were also observed. As compared with the controls, total content of JNKs was increased in the RV of the IHA rats, while expression of JNKs in the LV was down-regulated. IHA hypoxia changed neither total levels of Akt kinase in both RV and LV, nor Akt kinase activity in the RV. However, increased levels of activated phospho-Akt kinase were found in the LV of IHA rats. The results demonstrate that adaptation of rat hearts to chronic IHA hypoxia is associated with disctinct changes in the levels and/or activation of several regulatory proteins in two ventricles. The latter could be attributed to both myocardial remodeling and cardioprotection induced by chronic hypoxia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16714773

Source DB:  PubMed          Journal:  Gen Physiol Biophys        ISSN: 0231-5882            Impact factor:   1.512


  12 in total

1.  Mice deficient in Mkp-1 develop more severe pulmonary hypertension and greater lung protein levels of arginase in response to chronic hypoxia.

Authors:  Yi Jin; Thomas J Calvert; Bernadette Chen; Louis G Chicoine; Mandar Joshi; John Anthony Bauer; Yusen Liu; Leif D Nelin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-02-19       Impact factor: 4.733

2.  Differential role of PI3K/Akt pathway in the infarct size limitation and antiarrhythmic protection in the rat heart.

Authors:  Tána Ravingerová; Jana Matejíková; Jan Neckár; Eva Andelová; Frantisek Kolár
Journal:  Mol Cell Biochem       Date:  2006-10-03       Impact factor: 3.396

3.  Identification of a NF-κB cardioprotective gene program: NF-κB regulation of Hsp70.1 contributes to cardioprotection after permanent coronary occlusion.

Authors:  Michael E Wilhide; Michael Tranter; Xiaoping Ren; Jing Chen; Maureen A Sartor; Mario Medvedovic; W Keith Jones
Journal:  J Mol Cell Cardiol       Date:  2011-03-23       Impact factor: 5.000

4.  Chronic hypoxia increases pressure-dependent myogenic tone of the uterine artery in pregnant sheep: role of ERK/PKC pathway.

Authors:  Katherine Chang; Daliao Xiao; Xiaohui Huang; Lawrence D Longo; Lubo Zhang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-04-17       Impact factor: 4.733

5.  Chronic intermittent hypoxia affects the cytosolic phospholipase A2α/cyclooxygenase 2 pathway via β2-adrenoceptor-mediated ERK/p38 stimulation.

Authors:  Petra Micova; Klara Hahnova; Marketa Hlavackova; Barbara Elsnicova; Anna Chytilova; Kristyna Holzerova; Jitka Zurmanova; Jan Neckar; Frantisek Kolar; Olga Novakova; Jiri Novotny
Journal:  Mol Cell Biochem       Date:  2016-09-30       Impact factor: 3.396

Review 6.  The involvement of protein kinases in the cardioprotective effect of chronic hypoxia.

Authors:  N V Naryzhnaya; H-J Ma; L N Maslov
Journal:  Physiol Res       Date:  2020-11-02       Impact factor: 1.881

7.  Quercetin improves postischemic recovery of heart function in doxorubicin-treated rats and prevents doxorubicin-induced matrix metalloproteinase-2 activation and apoptosis induction.

Authors:  Monika Barteková; Petra Šimončíková; Mária Fogarassyová; Monika Ivanová; Ľudmila Okruhlicová; Narcisa Tribulová; Ima Dovinová; Miroslav Barančík
Journal:  Int J Mol Sci       Date:  2015-04-13       Impact factor: 5.923

8.  Chronic hypoxia inhibits MMP-2 activation and cellular invasion in human cardiac myofibroblasts.

Authors:  Kirsten Riches; Michael E Morley; Neil A Turner; David J O'Regan; Stephen G Ball; Chris Peers; Karen E Porter
Journal:  J Mol Cell Cardiol       Date:  2009-06-11       Impact factor: 5.000

9.  ZFP580, a novel zinc-finger transcription factor, is involved in cardioprotection of intermittent high-altitude hypoxia against myocardial ischemia-reperfusion injury.

Authors:  Xiang-Yan Meng; Hai-Long Yu; Wen-Cheng Zhang; Tian-Hui Wang; Xia Mai; Hong-Tao Liu; Rui-Cheng Xu
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

10.  Upregulated ATF6 contributes to chronic intermittent hypoxia-afforded protection against myocardial ischemia/reperfusion injury.

Authors:  Weikun Jia; Zhao Jian; Jingwei Li; Lin Luo; Liang Zhao; Yang Zhou; Fuqin Tang; Yingbin Xiao
Journal:  Int J Mol Med       Date:  2016-03-22       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.